Biohaven (BHVN)

Biohaven Specialty Pharmaceutical Ltd. • Biohaven Therapeutics Ltd. • Biohaven Pharmaceuticals, Inc. • BioShin Limited • BioShin Hong Kong Limited • BioShin (Shanghai) Consulting Services Co., Limited • Biohaven Bioscience Ireland Limited • Biohaven Therapeutics IP Ltd. • Biohaven CGRP IP Ltd. • BioShin (Singapore) PTE. LTD. ...

BHVN stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$19.25

Low target

$11.00

High target

$26.00

Latest filings (excl ownership)

View all

Prospectus supplement for primary offering

13 Nov 25

424B5

Prospectus supplement for primary offering

10 Nov 25

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

10 Nov 25

8-K

Regulation FD Disclosure

Prospectus with selling stockholder info

11 Aug 25

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

11 Aug 25

Latest ownership filings

View all

Beneficial ownership report

14 Nov 25

SCHEDULE 13G/A

Beneficial ownership report (amended)

30 Oct 25

SCHEDULE 13G/A

Beneficial ownership report (amended)

14 Aug 25

SC 13G/A

JANUS HENDERSON GROUP PLC

14 May 25

Irina Antonijevic

7 May 25

Michael Thomas Heffernan

7 May 25

Financial summary

Financial statements Chart BHVN financial data

Quarter (USD)	Sep 25	Jun 25	Mar 25	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	188.38 mm	188.38 mm	188.38 mm	188.38 mm	188.38 mm	188.38 mm
Cash burn (monthly)	(no burn)	(no burn)	57.74 mm	66.37 mm	48.57 mm	54.13 mm
Cash used (since last report)	n/a	n/a	135.56 mm	155.82 mm	114.04 mm	127.08 mm
Cash remaining	n/a	n/a	52.82 mm	32.57 mm	74.35 mm	61.31 mm
Runway (months of cash)	n/a	n/a	0.9	0.5	1.5	1.1

Beta Read what these cash burn values mean

Financial data from Biohaven earnings reports.

Institutional ownership, Q4 2024

BHVN institutional ownership history Ownership history

87.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	257	254	+1.2%
Opened positions	48	53	-9.4%
Closed positions	45	25	+80.0%
Increased positions	102	76	+34.2%
Reduced positions	64	80	-20.0%

13F shares	Current	Prev Q	Change
Total value	3.33 tn	4.07 tn	-18.1%
Total shares	92.26 mm	85.40 mm	+8.0%
Total puts	445.80 k	751.10 k	-40.6%
Total calls	664.10 k	1.13 mm	-41.1%
Total put/call ratio	0.7	0.7	+0.8%

Largest owners	Shares	Value	Change
Vanguard	8.41 mm	$314.27 bn	+8.1%
BlackRock	7.67 mm	$286.37 bn	+11.5%
JHG Janus Henderson	6.98 mm	$260.73 bn	+12.1%
SF Stifel Financial	6.56 mm	$244.99 bn	+0.8%
Suvretta Capital Management	5.62 mm	$209.92 bn	+8.1%
Farallon Capital Management	4.43 mm	$165.39 bn	+21.6%
STT State Street	3.51 mm	$131.19 bn	+7.9%
T. Rowe Price	3.41 mm	$127.45 mm	-0.8%
RP Management	2.94 mm	$146.74 bn	0.0%
FMR	2.11 mm	$78.97 bn	+14.8%

Largest transactions	Shares	Bought/sold	Change
Perceptive Advisors	0.00	-1.49 mm	EXIT
JPM JPMorgan Chase & Co.	1.98 mm	+1.17 mm	+144.5%
Adage Capital Partners GP, L.L.C.	575.00 k	-907.49 k	-61.2%
Norges Bank	902.57 k	+902.57 k	NEW
BlackRock	7.67 mm	+789.83 k	+11.5%
Farallon Capital Management	4.43 mm	+785.58 k	+21.6%
JHG Janus Henderson	6.98 mm	+756.03 k	+12.1%
Vanguard	8.41 mm	+628.21 k	+8.1%
UBS UBS	747.72 k	+621.63 k	+493.0%
Point72 Asset Management	922.97 k	-577.32 k	-38.5%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BHVN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 Nov 25	George C. Clark	Common Shares	Buy	Acquire P	Yes	No	8.5159	17,000	144.77 k	20,000
13 Nov 25	Coric Vlad	Common Shares	Buy	Acquire P	Yes	No	7.5	333,333	2.50 mm	740,546
13 Nov 25	Coric Vlad	Common Shares	Buy	Acquire P	Yes	No	7.5	333,333	2.50 mm	1,195,275
13 Nov 25	Childs John W	Common Shares	Buy	Acquire P	Yes	No	7.5	3,333,333	25.00 mm	5,653,904
13 Nov 25	Bailey Gregory	Common Shares	Buy	Acquire P	No	No	7.5	400,000	3.00 mm	2,020,071
5 May 25	Childs John W	Stock Options Common Shares	Grant	Acquire A	No	No	22.62	31,716	717.42 k	31,716